These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1621 related articles for article (PubMed ID: 8441268)

  • 1. Preimmunization of mice with formalinized extracellular antigens of melanoma in combination with IL-2 and surgical resection increased survival and tumor control in metastatic melanoma model.
    Shrayer D; Koness J; Kouttab N; Bogaars H; Hearing VJ; Gersten DM; Maizel A; Wanebo H
    J Surg Oncol; 1993 Mar; 52(3):142-9. PubMed ID: 8441268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of interleukin-2, natural killer cell activity and anti-melanoma antibodies resulting from immunization of mice with formalinized extracellular antigens (FECA) of murine melanoma.
    Shrayer D; Koness J; Maizel A; Wanebo H
    Melanoma Res; 1992 May; 2(1):47-56. PubMed ID: 1643424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nude mouse model to study passive humoral immunotherapy directed against B16 F10 murine melanoma.
    Shrayer D; Bogaars H; Gersten D; Hearing V; Maizel A; Wanebo H
    J Surg Oncol; 1994 Sep; 57(1):50-6. PubMed ID: 8065154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further characterization of a clinically relevant model of melanoma metastasis and an effective vaccine.
    Shrayer D; Bogaars H; Hearing VJ; Maizel A; Wanebo H
    Cancer Immunol Immunother; 1995 May; 40(5):277-82. PubMed ID: 7600558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of tumor-specific cytotoxic T lymphocytes in vivo by combined treatment with inactivated tumor cells and recombinant interleukin-2.
    Harada M; Matsuzaki G; Shinomiya Y; Kurosawa S; Ito O; Okamoto T; Takenoyama M; Sumitika H; Nishimura Y; Nomoto K
    Cancer Immunol Immunother; 1994 May; 38(5):332-8. PubMed ID: 8162615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new mouse model of experimental melanoma for vaccine and lymphokine therapy.
    Shrayer DP; Bogaars H; Wolf SF; Hearing VJ; Wanebo HJ
    Int J Oncol; 1998 Aug; 13(2):361-74. PubMed ID: 9664134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with interleukin-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens prolongs the survival of mice with melanoma.
    Kim TS; Russell SJ; Collins MK; Cohen EP
    Int J Cancer; 1993 Nov; 55(5):865-72. PubMed ID: 8244584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of cytotoxic antibodies to the B16 murine melanoma using a formalinized vaccine.
    Shrayer D; Kouttab N; Maizel A; Wanebo H; Hearing VJ; Gersten DM
    Int J Cancer; 1993 Feb; 53(4):696-702. PubMed ID: 8436442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated expression of melanoma antigen gp75 as immunotherapy for metastatic melanoma.
    Hirschowitz EA; Leonard S; Song W; Ferris B; Leopold PL; Lewis JJ; Bowne WB; Wang S; Houghton AN; Crystal RG
    Gene Ther; 1998 Jul; 5(7):975-83. PubMed ID: 9813669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of polyvalent and monovalent vaccines coupled with interleukin-2 in a metastatic melanoma model.
    Shrayer D; Koness J; Kouttab N; Bogaars H; Hearing V; Maizel A; Wanebo H
    Int J Oncol; 1994 May; 4(5):1121-7. PubMed ID: 21567029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrogation of B16 melanoma metastases by long-term low-dose interleukin-6 therapy.
    Katz A; Shulman LM; Porgador A; Revel M; Feldman M; Eisenbach L
    J Immunother Emphasis Tumor Immunol; 1993 Feb; 13(2):98-109. PubMed ID: 8318501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebral versus subcutaneous immunization with allogeneic fibroblasts genetically engineered to secrete interleukin-2 in the treatment of central nervous system glioma and melanoma.
    Glick RP; Lichtor T; Mogharbel A; Taylor CA; Cohen EP
    Neurosurgery; 1997 Oct; 41(4):898-906; discussion 906-7. PubMed ID: 9316052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of mice with irradiated melanoma tumor cells transfected to secrete lymphokines and coupled with IL-2 or GM-CSF therapy.
    Shrayer DP; Bogaars H; Hearing VJ; Wanebo HJ
    J Exp Ther Oncol; 1996 Mar; 1(2):126-33. PubMed ID: 9414396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
    Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
    Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
    Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
    Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma.
    Lucas ML; Heller R
    DNA Cell Biol; 2003 Dec; 22(12):755-63. PubMed ID: 14683586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of metastases with lymphocytes treated with exogenous RNA in mice bearing B16 melanoma.
    Watanabe MA; Almeida DO; Serrano SV; Sales VS; Soares FA; de Lucca FL
    Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):393-8. PubMed ID: 9193794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose total body irradiation augments the therapeutic effect of interleukin-2 in a mouse model for metastatic malignant melanoma.
    Safwat A; Aggerholm N; Roitt I; Overgaard J; Hokland M
    J Exp Ther Oncol; 2003; 3(4):161-8. PubMed ID: 14567287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined local hyperthermia and immunotherapy treatment of an experimental subcutaneous murine melanoma.
    Geehan DM; Fabian DF; Lefor AT
    J Surg Oncol; 1995 May; 59(1):35-9. PubMed ID: 7745975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity to B16 melanoma in mice immunized with IL-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens.
    Kim TS; Russell SJ; Collins MK; Cohen EP
    Int J Cancer; 1992 May; 51(2):283-9. PubMed ID: 1533203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 82.